These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 24784910

  • 1. The effect of the Missouri WISEWOMAN program on control of hypertension, hypercholesterolemia, and elevated blood glucose among low-income women.
    Homan SG, McBride DG, Yun S.
    Prev Chronic Dis; 2014 May 01; 11():E74. PubMed ID: 24784910
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women.
    Finkelstein EA, Khavjou O, Will JC.
    J Womens Health (Larchmt); 2006 May 01; 15(4):379-89. PubMed ID: 16724886
    [Abstract] [Full Text] [Related]

  • 3. Cost Effectiveness of Two Lifestyle Interventions in the Vermont WISEWOMAN Program.
    Johnson A, Maiberger M, Donegan S, Kaplan NC, Kinner P.
    Prev Chronic Dis; 2019 Mar 21; 16():E31. PubMed ID: 30900547
    [Abstract] [Full Text] [Related]

  • 4. An Integrated Approach to Addressing Chronic Disease Risk Factors in Financially Disadvantaged Women in South Carolina.
    Tabung FK, Daguisé VG, Lydiard D, Steck SE.
    Am J Health Promot; 2017 Jul 21; 31(4):325-332. PubMed ID: 26730554
    [Abstract] [Full Text] [Related]

  • 5. A captive audience: bringing the WISEWOMAN program to South Dakota prisoners.
    Khavjou OA, Clarke J, Hofeldt RM, Lihs P, Loo RK, Prabhu M, Schmidt N, Stockmyer CK, Will JC.
    Womens Health Issues; 2007 Jul 21; 17(4):193-201. PubMed ID: 17572105
    [Abstract] [Full Text] [Related]

  • 6. Recall of three heart disease risk factor diagnoses among low-income women.
    Khavjou OA, Finkelstein EA, Farris R, Will JC.
    J Womens Health (Larchmt); 2009 May 21; 18(5):667-75. PubMed ID: 19405860
    [Abstract] [Full Text] [Related]

  • 7. Clinic-based nutrition and lifestyle counseling for Hispanic women delivered by community health workers: design of the California WISEWOMAN study.
    Farrell MA, Hayashi T, Loo RK, Rocha DA, Sanders C, Hernandez M, Will JC.
    J Womens Health (Larchmt); 2009 May 21; 18(5):733-9. PubMed ID: 19445619
    [Abstract] [Full Text] [Related]

  • 8. WISEWOMAN: addressing the needs of women at high risk for cardiovascular disease.
    Vaid I, Wigington C, Borbely D, Ferry P, Manheim D.
    J Womens Health (Larchmt); 2011 Jul 21; 20(7):977-82. PubMed ID: 21668383
    [Abstract] [Full Text] [Related]

  • 9. Integrating preventive health services within community health centers: lessons from WISEWOMAN.
    Mays GP, Hesketh HA, Ammerman AS, Stockmyer CK, Johnson TL, Bayne-Smith M.
    J Womens Health (Larchmt); 2004 Jun 21; 13(5):607-15. PubMed ID: 15257852
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular disease risk reduction: the Massachusetts WISEWOMAN project.
    Stoddard AM, Palombo R, Troped PJ, Sorensen G, Will JC.
    J Womens Health (Larchmt); 2004 Jun 21; 13(5):539-46. PubMed ID: 15257845
    [Abstract] [Full Text] [Related]

  • 11. Determinants of major cardiovascular risk factors among participants of the South Carolina WISEWOMAN program, 2009-2012.
    Nahhas GJ, Daguise V, Ortaglia A, Merchant AT.
    Prev Chronic Dis; 2014 Sep 04; 11():E153. PubMed ID: 25188278
    [Abstract] [Full Text] [Related]

  • 12. The frequency and distribution of cardiovascular disease risk factors among Nebraska women enrolled in the WISEWOMAN screening program.
    Feresu SA, Zhang W, Puumala SE, Ullrich F, Anderson JR.
    J Womens Health (Larchmt); 2008 May 04; 17(4):607-17. PubMed ID: 18345998
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of a cardiovascular disease risk reduction program aimed at financially vulnerable women: the Massachusetts WISEWOMAN project.
    Finkelstein EA, Troped PJ, Will JC, Palombo R.
    J Womens Health Gend Based Med; 2002 May 04; 11(6):519-26. PubMed ID: 12243129
    [Abstract] [Full Text] [Related]

  • 14. Women with Blood Pressure Improvement in the Well-Integrated Screening and Evaluation for Women Across the Nation Program by Race and Ethnicity, 2014-2018.
    Vaid I, Blum E, Nwaise I.
    J Womens Health (Larchmt); 2024 Apr 04; 33(4):467-472. PubMed ID: 38451720
    [Abstract] [Full Text] [Related]

  • 15. Smoking Cessation Efforts Among WISEWOMAN Program Participants, 2014-2018.
    Vaid I, Blum E, Ahmed K.
    J Womens Health (Larchmt); 2022 Jul 04; 31(7):911-916. PubMed ID: 35849753
    [Abstract] [Full Text] [Related]

  • 16. Provider counseling, health education, and community health workers: the Arizona WISEWOMAN project.
    Staten LK, Gregory-Mercado KY, Ranger-Moore J, Will JC, Giuliano AR, Ford ES, Marshall J.
    J Womens Health (Larchmt); 2004 Jun 04; 13(5):547-56. PubMed ID: 15257846
    [Abstract] [Full Text] [Related]

  • 17. The impact of medication use in a multicomponent intervention: results from the WISEWOMAN program.
    Khavjou OA, Finkelstein EA, Will JC.
    Am J Health Promot; 2007 Jun 04; 21(4):267-73. PubMed ID: 17375493
    [Abstract] [Full Text] [Related]

  • 18. Medical Follow-Up Received by Women with Blood Pressure Alerts in the WISEWOMAN Program by Race and Ethnicity, 2014-2018.
    Nwaise I, Vaid I, Blum E.
    J Womens Health (Larchmt); 2022 Sep 04; 31(9):1353-1357. PubMed ID: 35420456
    [Abstract] [Full Text] [Related]

  • 19. Implementing the WISEWOMAN program in local health departments: staff attitudes, beliefs, and perceived barriers.
    Jilcott SB, Macon ML, Rosamond WD, Garcia BA, Jenkins LK, Cannon PM, Townsend CR, Tawney KW, Keyserling TC, Will JC, Ammerman AS.
    J Womens Health (Larchmt); 2004 Jun 04; 13(5):598-606. PubMed ID: 15257851
    [Abstract] [Full Text] [Related]

  • 20. Expanding the evidence for health promotion: developing best practices for WISEWOMAN.
    Farris RP, Haney DM, Dunet DO.
    J Womens Health (Larchmt); 2004 Jun 04; 13(5):634-43. PubMed ID: 15257855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.